<DOC>
	<DOCNO>NCT00163410</DOCNO>
	<brief_summary>The aim study compare efficacy ciclesonide versus fluticasone propionate lung function , symptom , use rescue medication child persistent asthma . Ciclesonide inhale one dose level daily ; fluticasone propionate inhale one dose level twice daily . The study duration consist baseline period ( 2 4 week ) treatment period ( 12 week ) . The study provide data safety tolerability ciclesonide .</brief_summary>
	<brief_title>Efficacy Ciclesonide Inhaled Once Daily Versus Fluticasone Propionate Inhaled Twice Daily Children With Asthma ( 4 15 ) ( BY9010/M1-205 )</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Ciclesonide</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Main History persistent bronchial asthma least 6 month FEV1 5090 % predict Main Concomitant severe disease disease contraindication use inhaled steroid COPD ( chronic bronchitis emphysema ) and/or relevant lung disease cause alternate impairment lung function Respiratory tract infection asthma exacerbation within last 30 day prior entry study History lifethreatening asthma Premature birth Current smoking Smoking history either equal 10 packyears Pregnancy Intention become pregnant course study Breast feeding Lack safe contraception</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Ciclesonide</keyword>
	<keyword>Child</keyword>
	<keyword>Fluticasone propionate</keyword>
	<keyword>Pediatric</keyword>
</DOC>